BlackRock's position in Johnson & Johnson is currently worth $48.7B. That's 0.74% of their equity portfolio (18th largest holding). The investor owns 8.98% of the outstanding Johnson & Johnson stock. The first Johnson & Johnson trade was made in Q4 2020. Since then BlackRock bought shares twelve more times and sold shares on five occasions. The stake costed the investor $32.5B, netting the investor a gain of 50% so far.
Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript
With Q1 earnings season well underway, it was Johnson & Johnson (JNJ) giving investors a peek at how the broader healthcare sector might perform. The healthc...
Healthcare may be considered a defensive sector, but not all healthcare stocks make for strong defensive plays. For one, consider it best to focus on healthc...
Johnson & Johnson (NYSE:JNJ)'s Spravato is reinforcing investor interest in the broader psychedelics sector as it reported another quarter of strong sales gr...